The Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Cardiology (SEC) presented a recommendation for recommendations regarding the management of hyperpotasmia in patients with cardiac insufficiency. In Europe, a 2 per cent population Cardiac insufficiency (ICA) and the prevalence of the Cardiac insufficiency (IC) in Spain stands at 6.8 per cent for the population of more than 45 years.
In patients IC the use of inhibitors of the renina-angiotensin-aldosterone system (iSRAA) se associate with a functional major, increment of the quality of life percibida, reduction of the probability of cardiovascular death and reduction of the number of hospitalizations.
The signal informs that some of these pharmacies also result in efficacies in patients with chronic renal disease and albuminuria, as well as patients with arterial resistance hypertension.
In addition to its beneficial numbers, the iSRAA is associated with a Increase in the incidence of hyperpotasemia, on all patients with chronic renal insufficiency chronic concomitant.
Hyperpotasmemia
‘Hyperpotasmia is a frequent ionic trastorn which is defined as the elevation of plasmatic concentrations of potassium, and is related to the presence of rehospitalizations, malignant cardiac arrhythmias and increase in mortality. On the other hand, an optimized treatment with iSRAA requires progressive increments of the doses that can be given to a mayor with a high probability of hyperpotasemia, ”explains the informant.
For all these, both companies signal that “it is necessary to establish one regstukke para el manejo y tratamiento de estos patient”. This consensus document was prepared by a group of 10 experts and revised by a panel of 10 other specialists in the treatment of patients with IC (altogether 10 cardiologists and 10 internists).
Although it contains statements, dates or appointments of institutions or health care professionals, the information contained in Redacción Médica is edited and elaborated by periodicals. We recommend to the reader that any relationship with the health be consulted with a health care professional.